![Jakob Dynnes Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jakob Dynnes Hansen
Directeur Financier/CFO chez
ASARINA PHARMA AB
Profil
Mr. Jakob Dynnes Hansen is an Independent Director at Nanexa AB, a Chief Financial Officer at Asarina Pharma AB and a Chief Financial Officer at Zerion Pharma A/S.
He is on the Board of Directors at Nanexa AB. Mr. Hansen was previously employed as a Chief Financial Officer by Evolva Holding SA, a Chief Financial Officer by Evolva SA, a Chief Financial Officer & Director by Allylix, Inc., a Secretary by Galecto, Inc., a Head-Market Research by Novo Nordisk A/S, a Chief Financial Officer by Nuevolution AB, a Senior Vice President-Corporate Finance by Unibank (Denmark), and a Chief Financial Officer by Zealand Pharma A/S.
He received his graduate degree from the University of Copenhagen and an MBA from INSEAD.
Postes actifs de Jakob Dynnes Hansen
| Sociétés | Poste | Début |
|---|---|---|
| ASARINA PHARMA AB | Directeur Financier/CFO | 01/04/2017 |
| NANEXA AB | Directeur/Membre du Conseil | 01/01/2023 |
Zerion Pharma A/S | Directeur Financier/CFO | - |
Anciens postes connus de Jakob Dynnes Hansen
| Sociétés | Poste | Fin |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Secrétaire Général | 01/04/2020 |
| EVONEXT HOLDINGS SA | Directeur Financier/CFO | 31/12/2016 |
Allylix, Inc.
 Allylix, Inc. Pharmaceuticals: OtherHealth Technology Develops terpene products and their derivatives | Directeur Financier/CFO | - |
Unibank (Denmark)
 Unibank (Denmark) Major BanksFinance Operates as a nationally chartered commercial bank | Directeur Financier/CFO | - |
Evolva SA
 Evolva SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company focused on the research, development and commercialization of ingredients based on nature | Directeur Financier/CFO | - |
Formation de Jakob Dynnes Hansen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
43
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Allylix, Inc.
Allylix, Inc. Pharmaceuticals: OtherHealth Technology Develops terpene products and their derivatives | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unibank (Denmark)
Unibank (Denmark) Major BanksFinance Operates as a nationally chartered commercial bank | Finance |
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases | Health Technology |
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company focused on the research, development and commercialization of ingredients based on nature | Commercial Services |
Evolva Holding SA
 Evolva Holding SA Food: Specialty/CandyConsumer Non-Durables Develops and sells flavors, fragrances and health ingredients | Consumer Non-Durables |
Asarina Pharma AB
 Asarina Pharma AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Nanexa AB
 Nanexa AB Medical SpecialtiesHealth Technology Operates as a research intensive technology company | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Zerion Pharma A/S |
